Compound: Ponatinib

Drug Target: ABL, PDGFRA, VEGFR2, FGFR1, SRC, TIE2, FLT3

Drug Target pathway: Other, kinases

Dataset


Tissue specific analysis

Contact us | Cookies policy | Terms & Conditions. This site is hosted by the Wellcome Sanger Institute.